June 13, 2025 04:42 PM EDTUpdated 05:00 PM

KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’

Jaimy Lee

Deputy Editor

KalVista Pharmaceuticals said Friday that the FDA pushed back its decision on whether to approve its on-demand oral drug for hereditary angioedema, citing “heavy workload …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’

Jaimy Lee

Deputy Editor

Sign up to read this article for free.

RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone

Have sky-high sales projections set the obesity market up to fail?

Bristol Myers gets a key strategist with 'Team Shibs'; Idorsia to change CEOs after it 'hit a reset button'

Another round of consolidation is coming, FDA commissioner tells staff

AstraZeneca inks AI drug R&D deal with Chinese pharma for $110M upfront

McKesson leads the charge in revolutionizing precision oncology in community practices

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’

Jaimy Lee

Deputy Editor

Sign up to read this article for free.

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Bris­tol My­ers gets a key strate­gist with 'Team Shib­s'; Idor­sia to change CEOs af­ter it 'hit a re­set but­ton'

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

As­traZeneca inks AI drug R&D deal with Chi­nese phar­ma for $110M up­front

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’

RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone

Have sky-high sales projections set the obesity market up to fail?

Bristol Myers gets a key strategist with 'Team Shibs'; Idorsia to change CEOs after it 'hit a reset button'

Another round of consolidation is coming, FDA commissioner tells staff

AstraZeneca inks AI drug R&D deal with Chinese pharma for $110M upfront

McKesson leads the charge in revolutionizing precision oncology in community practices